Sched.com Conference Mobile Apps
DIA 2024 Global Annual Meeting
Attending this event?
Log In
or
log in with email →
Sign Up
or
sign up with email →
Completely free and you can…
Create a custom schedule.
Take it with you on mobile.
Get listed in the directory.
DIA 2024 Global Annual Meeting
-
Saved To
My Schedule
Schedule
Simple
Expanded
Grid
By Venue
Speakers
Search
or browse by date + venue
00: Plenary
All
Forum
01: ClinSafety-PV
All
Forum
Session
Workshop
02: ClinTrials -ClinOps
All
Forum
Session
Workshop
03: Data-Tech
All
Forum
Session
Workshop
04: MedAffairs-SciComm
All
Forum
Session
Workshop
05: Patient-Focused Drug Dev
All
Forum
Session
Workshop
06: TranslationalDelivery Tech-PrecMedicine
All
Forum
Session
07: ProjectManagement-StrategicPlanning
All
Forum
Session
08: RD Quality-Compliance
All
Forum
Session
Tutorial
09: Regulatory
All
Forum
Session
Workshop
10: RegCMC-Product Quality
All
Forum
Session
Workshop
11: Statistics-Data Science
All
Forum
Session
Workshop
12: Value-Access
All
Forum
Session
Workshop
13: ProfDevelopment
All
Forum
Session
Tutorial
Workshop
14: DIAmond
All
Forum
15: Content Hubs
All
Workshop
16: Community Rounds
All
Session
17: Networking Opportunities
All
Session
Social Event
Social Evt / Reception
18: Posters
All
Session
19: InnovationTheaters
All
Session
20: Networking Opportunities
All
Session
20: Short Courses
All
Tutorial
Blood Drive
All
Social Event
Format
Forum
Session
Tutorial
Workshop
Level
Advanced
Basic
Intermediate
Featured Topics
Artificial Intelligence (AI)
Cell and Gene Therapy
Decentralized Clinical Trials (DCTs)
Digital Technology
Diversity Equity and Inclusion (DEI)
Ethics
ICH
Patient Focused
Rare Disease
Real-World Data (RWD)- Real-World Evidence (RWE)
Regulator Perspectives
Regulatory Collaboration
Regulatory Reliance
Risk Management
Special Populations
Student Programming
menu
Menu
Schedule
Speakers
Search
Cynthia Rothblum-Oviatt
FDA, United States
Science Policy Analyst, Rare Disease Team, OND, CDER
Isabelle Rousse
Health Canada, Canada
Associate Director, Bureau of Metabolism, Oncology, Reproductive...
Debabrata Roy
Drug Safety Research Unit, United Kingdom
Head of Epidemiology and Research
Todd Rudo
Clario, United States
EVP & Chief Medical Officer
Michelle Ruiz
Genentech, A Member of the Roche Group, United States
Principal Quality Data Analyst
Tanya Russell
Pfizer Inc, United States
Vice President, Integration Lead
Donna Rycroft
AbbVie, United States
Director, Study Risk Management
Anindita Saha
FDA, United States
Associate Director Strategic Initiatives, Digital Health Center of...
MS
Michiyo Sakiyama
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Senior Scientist for Clinical Medicine, Office of Vaccines...
Mary Jo Salerno
FDA, United States
Science Policy Analyst, ORDPURM, OND, CDER
CS
Claudia Salinas
Eli Lilly and Company, United States
Senior Director, GPS Pharmacoepidemiology
Leslie Sam
Leslie Sam and Associates, LLC, United States
President
Bruna Sampaio
Hospital Israelita Albert Einstein, Brazil
Manager, Data management
Sharon Rivera Sanchez
Trials of Color, United States
Patient Advocate and Founder
Neetu Sangari
Pragya Tech Leaders, United States
President/CEO
Toshiharu Sano
MSD K.K., Japan
Associate Vice President, Head of Clinical Operation Area
TS
Toshihiro Sano
Merck Sharp & Dohme LLC , United States
Associate Vice President, Head of Clinical Operations
Sakshi Sardar
Critical Path Institute, United States
Senior Director, Digital and Precision Medicine
Caprice Sassano
HumanFirst, United States
Research and Data Products - Applied Sciences
SS
Steve Satek
Flourish Research, United States
Executive Vice President
Junko Sato
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director
Mayur Saxena
Droice Labs, United States
Chief Executive Officer
Claudia Schaffer
EMD Serono, Germany
Sr. Director, Head Case and Vendor Management
Jörg Schläpfer
Swissmedic, Switzerland
Head of Management Services and International Affairs
Tina Schlecht
RxE2, United States
Chief Pharmacy Officer
Hollie Schmidt
Accelerated Cure Project, United States
Vice President of Scientific Operations
Norman Schmuff
FDA, United States
Associate Director for Science, OPMA, OPQ
CS
Chris Schneiderman
Abbvie, United States
Epidemiologist
Andrew Schorr
Patient Advocate, United States
Founder, Web-Savvy Health Consultants, LLC
Duane Schulthess
Vital Transformation LLC, United States
Chief Executive Officer
James Schultz
Neighborhood Healthcare, United States
Chief Medical Officer
Rob Schulz
Suttons Creek, Inc., United States
President and COO
PPD, part of Thermo Fisher Scientific
United States
John Scott
FDA, United States
Division Director, Office of Biostatistics, CBER
Samantha Seepersad-Nayee
Excision Biotherapeutics, United States
AD
Abi Seifert
Novartis , United States
Global Head Country Development Quality
Eri Sekine
CMIC Group, Japan
Executive Vice President
Earl Seltzer
CTI, United States
Senior Director, Partnerships and Innovation
Leonardo Semprun
MSD, Panama
Global Regulatory Policy Lead-LatAm
Ana Sengupta
Mirum Pharmaceuticals, Inc., United States
Associate Director Regulatory Affairs CMC
Elizabeth Seyfert
Fortrea, United States
Head of Site Engagement and Partnership Delivery
Anjali Shah
Bristol-Myers Squibb Company, United States
Executive Director, Business Capabilities and Innovation, WWPS
Saad Shakir
Drug Safety Research Unit, United Kingdom
Director
Subhan Sharief
ArisGlobal LLC, United States
Senior Director
Khushboo Sharma
Accumulus Synergy, United States
Chief Regulatory Innovation Officer
Vishakha Sharma
Roche, United States
Senior Principal Data Scientist
T.J. Sharpe
Consultant, United States
Patient Engagement Expert
Laura Shaughnessy
UCB Biosciences, United States
Clinical Program Director
Jie Shen
AbbVie, United States
Director, Digital Science
Lichen Shen
Medidata, United States
Senior Director of Product R&D
RS
Roya Sherafat-Kazemzadeh
Mapi Research Trust, France
Scientific Director
Allison Cuff Shimooka
TransCelerate Biopharma Inc, United States
Chief Operating Officer
Tricha Shivas
Foundation For Sarcoidosis Research, United States
Chief of Staff and Strategy
JS
Jonathan Shough
Parexel , United States
Chief Information Officer
Jeffrey Siegel
FDA, United States
Director, Office of Drug Evaluation Sciences, OND, CDER
Hiiti Sillo
World Health Organization (WHO), Switzerland
Unit Head, Regulation and Safety, Department of Regulation and...
Pamela Simpkins
Mezzopointe. LLC, United States
Managing Partner
Kanwaljit Singh
Critical Path Institute, United States
Executive Director, International Neonatal Consortium
Romi Singh
GRA Advisors, United States
Founder & Principal Advisor
Mukesh Singhal
Deloitte, United States
Partner
Ranjeeta Sinvhal
AbbVie, United States
Executive Medical Director, Medical Safety
Louise Lind Skov
Novo Nordisk A/S, Denmark
Head of Content Digitalisation
Renata Skros
Network Partners Group, United States
Quality Consultant
Del Smith
Acclinate Inc., United States
Co-Founder and Chief Executive Officer
Meredith Smith
Evidera, Inc, United States
Senior Director, Implementation Science Pillar Lead
Cary Smithson
Leapahead Solutions, Inc., United States
Managing Partner
Cary Smithson
Leapahead Solutions, Inc., United States
Managing Partner
PS
Paul Smolenski
DEKA Research & Development Corp., United States
Regulatory
Patroula Smpokou
FDA, United States
Lead Physician, Division of Rare Diseases/Medical Genetics, OND, CDER
Donna Snyder
WCG, United States
Executive Physician
Rachel Sobel
Regeneron , United States
Vice President, Head of Pharmacoepidemiology
Alexandru Socolov
Medidata Solutions, United States
Senior Data Scientist
Elizabeth Somers
Merck Sharp & Dohme LLC, United States
Executive Director, Global Project and Alliance Management
Sophie Sommerer
Health Canada, Canada
Director General
Toni Spears
Sanofi, United States
Program Lead, Industry Collaborations
Jean Sposaro
Bristol-Myers Squibb Company, United States
Director, Global Drug Development Operations, Industry Collaborations
Srivdya Srikant
Gilead Sciences, United States
Director, Global Regulatory Affairs- CMC
Fannie St-Gelais
Health Canada, Canada
Manager, Health Product and Food Branch
Summer Starling
Clinical Trials Transformation Initiative (CTTI), United States
Senior Project Manager
AS
Andrew Stelzer
Unlearn.ai, United States
Head of Business Development
Benjamin Stevens
GlaxoSmithKline, United States
Director CMC Policy and Advocacy
Mark Stewart
Friends of Cancer Research, United States
Vice President, Science Policy
Oliver Stoss
Discovery Life Sciences Biomarker Services GmbH, Germany
Senior Vice President of Operations
Yoshiko Stowell
Head of Regulatory Affairs
Paul Strijbos
F. Hoffmann-La Roche Ltd, Switzerland
Senior Principal Neurotech Innovation Leader
Nancy Styple
Bayer AG, United States
Project Management Leader
Ling Su
Shenyang Pharmaceutical University, Yeehong Business School, China
Research Fellow
Karthick Sukumaran
Roche, United States
Technology Enablement Director
Linda Sullivan
Tufts Center For the Study of Drug Development, United States
Senior Fellow
John Sun
Novartis Pharmaceuticals Corporation, United States
Program Lead, Global Clinical Operation, Development
DS
Deeksha Surisetty
Georgetown University, United States
MS Biotechnology Student
Mike Sweeney
QuickSTAT, France
Global Head of Strategy, CGT & DTP
Kirsten Swingle
Regeneron, United States
Manager, Regulatory Submission Project Management
Thomas Switzer
Genentech, A Member of the Roche Group, United States
Principal Digital Health Scientist
CS
Chiang Syin
Meadows Biosolutions LLC, United States
President
Patricia Oliveira Pereira Tagliari
ANVISA, Brazil
Associate Director
JT
Julie Tai
GlaxoSmithKline, United States
Director, GRA, Precision Medicine and Digital Health
Susan Talbot
Amgen, United States
Director Biostatistics
Bhavana Tallavajhula
Bristol Myers Squibb, United States
Director
ST
Sharon Tamir
MT-Pharma, United States
Digital Healthcare Innovation, Business and Research Strategy
Daisuke Tanaka
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Office Director, Office of International Programs
Keisuke Tanaka
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer
Hiroya Taniguchi
Aichi Cancer Center Hospital, Japan
Department of Clinical Oncology
HT
HCL Technologies
United States
IQVIA Technologies
United States
Taimei Technology, Inc.
United States
Ana Tediosi
WEP Clinical, United Kingdom
Head of Expanded Access Strategy
Stacy Tegan
Transcelerate Biopharma, Inc., United States
Program Director
Steffen Thirstrup
European Medicines Agency, Netherlands
Chief Medical Officer
Alec Thompson
Gilead Sciences, United States
Senior Product Manager, Oncology
Chris Thompson
Woodley Trial Solutions, United Kingdom
Senior Operations Manager
Ramya Thota
Intermountain Medical Oncology - IMC, United States
Associate Professor
Aman Thukral
AbbVie, Inc., United States
Head of Digital Operations & Clinical Systems Data and...
Gert Thurau
F. Hoffmann-La Roche Ltd, Switzerland
Head of Manufacturing Technology Innovation in CMC Regulatory Policy
Julia Tierney
FDA, United States
Deputy Center Director for Strategy, Policy, and Legislation, CBER
BT
Bintou Timbine
University of Illinois Chicago, United States
PharmD Student
Wendy Tin
Gilead Sciences, United States
Associate Director, HIV PrEP Scientific Publications
Michael Torok
Genentech, A Member of the Roche Group, United States
Vice President, Global Head of Quality Assurance Programs
Antonio Barra Torres
ANVISA, Brazil
President Director
Cesar Torres
FDA, United States
Senior Mathematical Statistician, OB, OTS, CDER
Jeanette Towles
Synterex, Inc., United States
President and CEO
Eveline Trachsel
Swissmedic, Switzerland
Head of Medicinal Product Authorisation and Vigilance
Kimberly Trautman
Trautman International Services, United States
Managing Director
Kelly Traverso
Deloitte, United States
R&D Business Development
Phil Tregunno
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Deputy Director - Patient Safety Monitoring
Sarah Tremethick
Roche Products Limited
Global Consortia Program Lead, Product Development Industry...
Kiernan Trevett
Genentech, A Member of the Roche Group, United States
Principal Quality Lead, PDQ Quality Assurance Process GVP
PCM Trials
United States
Stelios Tsinontides
FDA, United States
Office Director, OPMA, OPQ, CDER
Atsushi Tsukamoto
Daiichi Sankyo, United States
Head is Therapeutic Area Strategies
Rachel Turow
Walmart, Inc., United States
Managing Counsel, FDA Regulatory
Peter Twomey
European Medicines Agency, Netherlands
Head of Inspections
YT
Yoni Tyberg
FDA, United States
Associate Director of Special Programs, Office of New Drugs, CDER
Katherine Tyner
FDA, United States
FDA Liaison to the EMA, Office of Global Policy and Strategy, OC
SU
Stephanie Ueng
Roche, United States
Strategy Director
Joseph Unger
Fred Hutchinson Cancer Center, United States
Associate Professor
Yoshiaki Uyama
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director
Pujita Vaidya
Novartis Pharmaceuticals Corporation, United States
Director, US Patient Engagement
James Valentine
Hyman, Phelps & McNamara, PC, United States
Director
HV
Haleh Valian
Biogen, United States
Head of Decision Quality Analytics and Innovation
Haritha Vallabhaneni
FDA, United States
Biological Reviewer, Office of Cellular Therapy and Human Tissue CMC,...
JV
Jacqueline Vanderpuye-Orgle
Parexel, United States
Vice President
Ruth GĂłmez Vargas
MSD, Colombia
Senior Medical Writer
Naeiry Vartevan
BASE Life Sciences, United States
VP, US R&D
AV
Akshay Vashist
Otsuka Pharmaceutical Development & Commercialization, United States
Exec Dir
Caroline Vass
RTI Health Solutions, United Kingdom
Senior Economist, Health Preference Assessment
Maria Vassileva
DIA, United States
Global Head of Science and Scientific Strategy
AV
Ashkan Vaziri
Biosensics, United States
Founder and CEO
Monica Veldman
Alliance for Regenerative Medicine, United States
Director, Global Regulatory Policy
Karthik Venkatakrishnan
EMD Serono, United States
Vice President, Global Head of Quantitative Pharmacology
Rayna Venook
Genentech, A Member of the Roche Group, United States
Team Lead, Pharma Development Regulatory
AV
Arnold Ventures
United States
Rebecca Vermeulen
Genentech, A Member of the Roche Group, United States
Vice President, Global Patient Networks | PD Medical Affairs
Cynthia Verst
IQVIA, United States
President, R&D Solutions D&DI; 2023 President
Shruti Vig
University of Maryland, College Park, United States
Graduate Student
Cesar Vinces
Accumulus Synergy, United States
EU Interim and International Policy Lead
Alyssa Vincze
Milliman IntelliScript
Principal and Director, R&D
Anders Vinther
QBA Leaders, United States
Founder and Chief Executive Officer
Manu Vohra
Box, United States
Managing Director, Life Sciences
Carolyn Volpe
FDA, United States
Team Leader, OSI, OC, CDER
Niam Vora
Srx Health Solutions, Canada
Pharmacist
Sejal Vora
BeiGene, United States
Director, Medical Information
James Wabby
AbbVie, United States
Global Head, Regulatory Affairs, Emerging Technologies and...
Brittin Wagner
PointClickCare, Canada
Senior Research Scientist
Peter Wahl
CorEvitas, part of PPD clinical research business of Thermo Fisher Scientific, United States
Vice President, Global Head of Scientific Affairs
L'Oreal Walker
FDA, United States
Supervisory Consumer Safety, OBIMO, ORA
Paula Walker
Roche Products Ltd., United Kingdom
Global Head of Risk Based Quality Management
Stuart Walker
Centre for Innovation In Regulatory Science (CIRS), United Kingdom
Professor and Consultant
Ramona Walls
Critical Path Institute, United States
Executive Director of Data Science, Data Collaboration Center
Matt Wampole
Clarivate, United States
Director, Solution Consulting
Hongwei Wang
AbbVie, United States
Director/ Senior Research Fellow
Susan Wang
Boehringer Ingelheim, United States
Global Head of Biostatistics and Data Sciences Inflammation
Jayne Ware
Merck Sharp & Dohme LLC, United States
Senior Director, Global Regulatory Policy
Jonathan Watanabe
University of California Irvine, United States
Associate Dean, Pharmacy Assessment and Quality | Prof, Clinical...
CW
Christina Waters
RARE Science, Inc., United States
Chief Executive Officer and Founder
J. Kyle Wathen
Cytel Inc., United States
Vice President, Scientific Strategy and Product Innovation
Susan Watson
Eli Lilly and Company, United States
Associate Director, Bioethics
Max Wegner
Bayer AG, Germany
Head Regulatory Affairs
BW
Brittany Weichers
Velocity, United States
Head of Global Patient Recruitment
Auren Weinberg
Veradigm, United States
Chief Medical Officer
EW
Eli Weinberg
Bain & Co., United States
Partner
Steven Weisman
Lumanity Inc, United States
Global President, Clinical and Regulatory
Ellen Weiss
PCM Trials, United States
Strategy, Decentralized Trials, Emeritus
KW
Kilian Weiss
Veeva, Germany
General Manager, Veeva Link and OpenData
Gerold Wharton
FDA, United States
Program Analyst, Office of Clinical Policy and Programs, OC
Emily Whitehead
Emily Whitehead Foundation, United States
Co-founder
Tom Whitehead
Emily Whitehead Foundation, United States
Co-founder and President
Robin Whitsell
Whitsell Innovations, Inc., United States
President
Mike Wierzba
GlaxoSmithKline, United States
Director, GRA, Precision Medicine and Digital Health
GW
Gary Wilkinson
Ryvu Therapeutics, Poland
Director of Clinical Pharmacology
SW
Sam Willcox
ACM Global Laboratories, United Kingdom
Section Manager - Large Molecule Bioanalysis
Kristin Willemsen
Canadian Generic Pharmaceutical Association, Canada
Vice President, Scientific and Regulatory Affairs
Kayla Williams
Takeda, United States
Director and Head, Oncology Medical Writing
Rebecca Williams
Essex, Part of Emmes Group, United States
Senior Clinical Trials Subject Matter Expert
FW
Forrest Williamson
Eli Lilly and Company, United States
Director of Pediatrics, Statistical Innovation Center
Katherine Wilson
Viatris, United States
Head, Global Regulatory Policy and Intelligence
Luman Wing
Cell and Gene Therapies, United States
Consultant
Steve Winitsky
Parexel International, United States
Vice President, Technical
RW
Rodney Winley
CSL Behring, United States
Senior Director, R&D Patient Partnerships
Kathleen Winson
Genentech, A Member of the Roche Group, United States
Executive Group Director, Product Development Regulatory
1
2
3
4
5